Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.

Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.

Item
http://www.wikidata.org/entity/Q46137935
Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.Early identification and treatment of communication and swallowing deficits in Parkinson disease.Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse.Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.
P2860

Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.

Item
http://www.wikidata.org/entity/Q46137935
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Evaluation of speech impairmen ...... h the role of pharmacotherapy.
@en
Evaluation of speech impairmen ...... h the role of pharmacotherapy.
@nl
type
label
Evaluation of speech impairmen ...... h the role of pharmacotherapy.
@en
Evaluation of speech impairmen ...... h the role of pharmacotherapy.
@nl
prefLabel
Evaluation of speech impairmen ...... h the role of pharmacotherapy.
@en
Evaluation of speech impairmen ...... h the role of pharmacotherapy.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Evaluation of speech impairmen ...... th the role of pharmacotherapy
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921